Vicencio J, Sánchez Bolaños C, Moreno Sánchez I, Brena D, Vejnar CE, Kukhtar D, Ruiz López M, Cots Ponjoan M, Rubio A, Melero NR, Crespo Cuadrado J, Carolis C, Pérez Pulido AJ, Giráldez AJ, Kleinstiver BP, Cerón J, Moreno Mateos MA. Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes. Nat. Commun. 2022;13(1):2601-2601. doi:10.1038/s41467-022-30228-4.
Martínez Fernández C, Bergamino M, Schiavi A, Brena D, Ventura N, Honnen S, Villanueva A, Nadal E, Cerón J. Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans. Dis. Model. Mech. 2022;15(3):doi:10.1242/dmm.049161.
Jungtrakoon Thamtarana P, Marucci A, Pannone L, Bonnefond A, Pezzilli S, Biagini T, Buranasupkajorn P, Hastings T, Mendonca C, Marselli L, Di Paola R, Abubakar Z, Mercuri L, Alberico F, Flex E, Ceròn J, Porta Riva M, Ludovico O, Carella M, Martinelli S, Marchetti P, Mazza T, Froguel P, Trischitta V, Doria A, Prudente S. Gain of function of Malate Dehydrogenase 2 (MDH2) and familial hyperglycemia. J. Clin. Endocrinol. Metab. 2022;107(3):668-684. doi:10.1210/clinem/dgab790.
Saura Esteller J, Sanchez Vera I, Nunez Vazquez S, Jabalquinto Carrasco J, Cosialls AM, Mendive Tapia L, Kukhtar D, Martinez Bueno MD, Lavilla R, Ceron J, Artal Sanz M, Pons G, Iglesias Serret D, Gil J. Fluorizoline-induced apoptosis requires prohibitins in nematodes and human cells. Apoptosis. 2021;26(1-2):83-95. doi:10.1007/s10495-020-01651-z.
Vicencio J, Ceron J. A Living Organism in your CRISPR Toolbox: Caenorhabditis elegans Is a Rapid and Efficient Model for Developing CRISPR-Cas Technologies. CRISPR J. 2021;4(1):32-42. doi:10.1089/crispr.2020.0103. I
